Keith T. Flaherty

Insider Reports History

Location
Boston, MA
Signature
/s/ James P. Reilly, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith T. Flaherty:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kinnate Biopharma Inc. Director Common Stock 0 $0 $2.59 03 Apr 2024 Direct
Clovis Oncology, Inc. Director Stock Option (right to buy) 42,223 10 Jun 2021 Direct
Checkmate Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 31 May 2022 Direct
Kinnate Biopharma Inc. Director Stock Option (right to buy) 0 03 Apr 2024 Direct

Insider Reports Filed by Keith T. Flaherty

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588924010428-flaherty-keith-t-2024-04-03 Kinnate Biopharma Inc. 03 Apr 2024 7 $0 4 Director 05 Apr 2024, 16:55
/report/000120919123036860-flaherty-keith-t-2023-06-12 Kinnate Biopharma Inc. 12 Jun 2023 1 $0 4 Director 13 Jun 2023, 18:28
/report/000120919122037027-flaherty-keith-t-2022-06-13 Kinnate Biopharma Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 17:01
/report/000089924322020091-flaherty-keith-t-2022-05-31 Checkmate Pharmaceuticals, Inc. 31 May 2022 3 $0 4 Director 31 May 2022, 10:12
/report/000089924321025179-flaherty-keith-t-2021-06-16 Checkmate Pharmaceuticals, Inc. 16 Jun 2021 1 $0 4 Director 21 Jun 2021, 21:24
/report/000120919121040397-flaherty-keith-t-2021-06-11 Kinnate Biopharma Inc. 11 Jun 2021 1 $0 4 Director 14 Jun 2021, 19:13
/report/000089924321023421-flaherty-keith-t-2021-06-10 Clovis Oncology, Inc. 10 Jun 2021 1 $0 4 Director 11 Jun 2021, 21:02